NCT01591421 2023-08-04P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer.Canadian Cancer Trials GroupPhase 1/2 Completed22 enrolled
NCT01349660 2020-06-17Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma MultiformeSCRI Development Innovations, LLCPhase 1/2 Completed88 enrolled 13 charts